HIGHLIGHTS
- who: August and colleagues from the Capital Medical University, China have published the article: PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer, in the Journal: (JOURNAL)
- what: The authors evaluated the clinical importance and prognostic usefulness of PTBPs in pan-cancer.
- how: The results showed that PTBP1 expression was associated with tumor immune subtypes of BLCA BRCA COAD ESCA GBM KIRC KIRP LGG LIHC LUAD LUSC PRAD SARC SKCM STAD TGCT and UCEC . The results indicated that PTBP1 may serve as a prognostic biomarker for ACC KIRP and LGG at the three . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.